Screener
Disc Medicine IRON CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from investing activities | ||
| Purchases of marketable securities | (93,762) | (347,250) |
| Maturities of marketable securities | 152,069 | 75,468 |
| Purchases of property and equipment | — | (851) |
| Net cash provided by (used in) investing activities | 58,307 | (272,633) |
| Cash flows from financing activities | ||
| Proceeds from sale of common stock in underwritten offering, net of issuance costs paid | — | 234,003 |
| Proceeds from sale of pre-funded warrants in underwritten offering, net of issuance costs paid | — | 9,386 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Disc Medicine's capex?
- Disc Medicine (IRON) reported capex of $0 in Q1 2026.
- How has Disc Medicine's capex changed year-over-year?
- Disc Medicine's capex decreased by 100.0% year-over-year, from $851K to $0.
- What is the long-term trend for Disc Medicine's capex?
- Over 2 years (2022 to 2025), Disc Medicine's capex has grown at a 148.6% compound annual growth rate (CAGR), from $151K to $933K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Disc Medicine's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude